April 1, 2020
Belgium-based FibriCheck, the maker of apps that monitor a user's heart rhythm, announced yesterday that it has developed a new version of its smartwatch offering that is capable of scanning for atrial fibrillation while the wearer is asleep.
FibriCheck said in a release that the updated app is currently nearing the end of user testing, and that it will be available for smartwatch manufacturers...
January 28, 2020
This morning digital cardiac health startup Eko announced that its atrial fibrillation and heart murmur detection algorithm landed a 510(k) FDA clearance. The new algorithms are designed to integrate with Eko’s stethoscope, which is already on the market, and be used by healthcare providers.
The company said it plans to add more algorithms in the future. Next up will be an ECG-based algorithm...
January 6, 2020
French digital health company Withings has unveiled its latest smartwatch dubbed ScanWatch, which will include an ECG and Sp02 sensor.
The watch comes with a PPG sensor, which will continuously monitor the user's heart rate and alert users if there is an irregularity. If any issues are detected, the watch will prompt the user to take an ECG reading. Watch wearers can read the ECG on the screen...
October 17, 2019
Fitbit will be working with the cardiovascular-focused Bristol-Myers Squibb-Pfizer Alliance to develop “educational content and guidance” that will help device owners recognize if they are at risk of atrial fibrillation, as well as to seek appropriate support and diagnosis of the condition.
A spokesperson for the companies noted that although the specifics of these programs are still in...
September 24, 2019
Fitbit and Belgium-based FibriCheck announced today that device owners living in certain UK countries now have access to a smartwatch app that uses photoplethysmography (PPG) to detect heart rhythm irregularities such as atrial fibrillation.
Available in Belgium, the UK, the Netherlands and Ireland, the CE-marked tool is similar to FibriCheck’s smartphone app in that it uses light and sensors to...
September 5, 2019
Alphabet’s life science branch Verily is teaming up with digital health startup iRhythm on a new initiative focused on creating screening, diagnosis and management tools for patients with atrial fibrillation.
The collaboration is specifically targeted at alerting patients with asymptomatic or silent atrial fibrillation about their condition. The goal is to develop products that not only identify...
April 24, 2019
Today Cardiogram, maker of a smartwatch app that uses a deep neural network technology to detect various heart conditions, announced that it has cut a deal with Oscar Health — the first such healthcare insurer agreement for the startup.
As part of the new agreement, Oscar Health members will be able to enter their insurance information and then download the Cardiogram app. While the Cardiogram...
March 18, 2019
This weekend, Stanford Medicine researchers presented the long-awaited results of the Apple Heart Study, which explored the performance of the Apple Watch’s heart rate sensor and an accompanying algorithm in detecting potential arrhythmias.
Funded by Apple and launched back in 2017, the research project enrolled 419,297 Apple Watch and iPhone owners. Among these users, 2,161 (roughly 0.5 percent...
October 10, 2018
Last week FibriCheck announced that it received FDA 510(k) clearance for its app, which uses a smartphone’s camera and artificial intelligence to monitor for heart rhythm disorders. With this, the Belgian company expects to bring its product to the US market sometime in 2019.
To identify atrial fibrillation, FibriCheck monitors the user's heart rhythm via photoplethysmography. From there, an...
September 12, 2018
Yesterday physIQ announced that the it got the FDA nod for its latest product, an atrial fibrillation detection analytics engine designed to be used in both a patient care setting and in clinical trials. The system is intended to give further clinical insights about patients' atrial fibrillation, and will work with the company’s other products already approved to provide data analyses.